Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration

Brain Research Bulletin

Volumn 57, Issue 2, 2002, Pages 205-209

  Bosetti, Francesca ^a   Seemann, Ruth ^a   Bell, Jane M ^a   Zahorchak, Robert ^b   Friedman, Elliott ^a   Rapoport, Stanley I ^a   Manickam, Pachiappan ^b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Research Genetics   (United States)

Author keywords

Bipolar disorder; Chronic; Mood stabilizer; Subacute

Indexed keywords

COMPLEMENTARY DNA; INITIATION FACTOR 3; INTERFERON RECEPTOR; LITHIUM CHLORIDE; MESSENGER RNA; PARATHYROID HORMONE; PROTEIN KINASE; SIGMA OPIATE RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN LEVEL; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; ENERGY METABOLISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; LITHIUM BLOOD LEVEL; MALE; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ADMINISTRATION, ORAL; ANIMALS; BRAIN CHEMISTRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LITHIUM CHLORIDE; MALE; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASES; RATS; RATS, INBRED F344; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0037081822     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00744-4     Document Type: Article

References (40)

1. Reduced brain inositol in lithium-treated rats
2. Comparative genome organization of vertebrates. The First International Workshop on Comparative Genome Organization
3. Pharmacological treatment of bipolar disorder throughout the life cycle
4. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18
5. Inositol trisphosphate and diacylglycerol as second messengers
6. Increased anterior cingulate and caudate activity in bipolar mania
7. Lithium salts in the treatment of psychotic excitement
8. Lithium decreases turnover of arachidonate in several phospholipids
9. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity
10. Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex
11. Expression profiling using cDNA microarrays
12. Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects
13. Clinical uses of lithium salts
14. Powerful tools for genetic analysis come of age
15. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain
16. Differential gene expression of livers from ApoE deficient mice
17. Initiation and adaptation: A paradigm for understanding psychotropic drug action
18. Anti-bipolar therapy: Mechanism of action of lithium
19. AP-1 and NF-κB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differently sensitive to inhibition by lithium
20. Lithium and brain signal transduction systems
21. 11C-glucose metabolism in manic and depressed patients
22. Structure, function and regulation of mammalian phospholipases A2
23. Overview of the mechanism of action of lithium in the brain: Fifty-year update
24. Neurobiology of lithium: An update
25. i-2 alpha-subunit mRNA levels in rat cortex
26. A novel mammalian lithium-sensitive enzyme with a dual enzymatic activity, 3′-phosphoadenosine 5′-phosphate phosphatase and inositol-polyphosphate 1-phosphatase
27. Evolutionary parameters of the transcribed mammalian genome: An analysis of 2,820 orthologous rodent and human sequences
28. G proteins: Implications for psychiatry
29. Long-term action of lithium: A role for transcriptional and posttranscriptional factors regulated by protein kinase C
30. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: A role for neurotrophic and neuroprotective effects in manic depressive illness
31. Signal transduction pathways. Molecular targets for lithium's actions
32. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain
33. 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain
34. In vivo gene expression profile analysis of human breast cancer progression
35. The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness
36. The sequence of the human genome
37. Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects
38. Gene expression profiling in human peripheral blood mononuclear cells using high-density filter-based cDNA microarrays
39. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: Potentiation by muscarinic receptor activation
40. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder